Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
PLoS Pathog ; 15(2): e1007329, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30818338

RESUMEN

Mycobacterial pathogens are the causative agents of chronic infectious diseases like tuberculosis and leprosy. Autophagy has recently emerged as an innate mechanism for defense against these intracellular pathogens. In vitro studies have shown that mycobacteria escaping from phagosomes into the cytosol are ubiquitinated and targeted by selective autophagy receptors. However, there is currently no in vivo evidence for the role of selective autophagy receptors in defense against mycobacteria, and the importance of autophagy in control of mycobacterial diseases remains controversial. Here we have used Mycobacterium marinum (Mm), which causes a tuberculosis-like disease in zebrafish, to investigate the function of two selective autophagy receptors, Optineurin (Optn) and SQSTM1 (p62), in host defense against a mycobacterial pathogen. To visualize the autophagy response to Mm in vivo, optn and p62 zebrafish mutant lines were generated in the background of a GFP-Lc3 autophagy reporter line. We found that loss-of-function mutation of optn or p62 reduces autophagic targeting of Mm, and increases susceptibility of the zebrafish host to Mm infection. Transient knockdown studies confirmed the requirement of both selective autophagy receptors for host resistance against Mm infection. For gain-of-function analysis, we overexpressed optn or p62 by mRNA injection and found this to increase the levels of GFP-Lc3 puncta in association with Mm and to reduce the Mm infection burden. Taken together, our results demonstrate that both Optn and p62 are required for autophagic host defense against mycobacterial infection and support that protection against tuberculosis disease may be achieved by therapeutic strategies that enhance selective autophagy.


Asunto(s)
Interacciones Huésped-Patógeno/fisiología , Infecciones por Mycobacterium no Tuberculosas/metabolismo , Mycobacterium marinum/patogenicidad , Animales , Animales Modificados Genéticamente , Autofagia/fisiología , Proteínas de Ciclo Celular , Modelos Animales de Enfermedad , Humanos , Macrófagos , Proteínas de Transporte de Membrana , Mycobacterium/patogenicidad , Infecciones por Mycobacterium/metabolismo , Fagosomas , Proteína Sequestosoma-1 , Factor de Transcripción TFIIIA/metabolismo , Tuberculosis , Ubiquitina , Pez Cebra/metabolismo , Proteínas de Pez Cebra/metabolismo
2.
Infect Immun ; 80(10): 3512-20, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22851747

RESUMEN

SecA2 is an ATPase present in some pathogenic Gram-positive bacteria, is required for translocation of a limited set of proteins across the cytosolic membrane, and plays an important role in virulence in several bacteria, including mycobacteria that cause diseases such as tuberculosis and leprosy. However, the mechanisms by which SecA2 affects virulence are incompletely understood. To investigate whether SecA2 modulates host immune responses in vivo, we studied Mycobacterium marinum infection in two different hosts: an established zebrafish model and a recently described mouse model. Here we show that M. marinum ΔsecA2 was attenuated for virulence in both host species and SecA2 was needed for normal granuloma numbers and for optimal tumor necrosis factor alpha response in both zebrafish and mice. M. marinum ΔsecA2 was more sensitive to SDS and had unique protrusions from its cell envelope when examined by cryo-electron tomography, suggesting that SecA2 is important for bacterial cell wall integrity. These results provide evidence that SecA2 induces granulomas and is required for bacterial modulation of the host response because it affects the mycobacterial cell envelope.


Asunto(s)
Adenosina Trifosfatasas/metabolismo , Proteínas Bacterianas/metabolismo , Granuloma/microbiología , Proteínas de Transporte de Membrana/metabolismo , Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium marinum/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Adenosina Trifosfatasas/genética , Animales , Proteínas Bacterianas/genética , Células Cultivadas , Femenino , Humanos , Inflamación/metabolismo , Macrófagos , Proteínas de Transporte de Membrana/genética , Ratones , Ratones Endogámicos C57BL , Infecciones por Mycobacterium no Tuberculosas/inmunología , Infecciones por Mycobacterium no Tuberculosas/metabolismo , Mycobacterium marinum/genética , Mycobacterium marinum/patogenicidad , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Necrosis Tumoral alfa/genética , Virulencia , Pez Cebra
3.
J Immunol ; 187(9): 4744-53, 2011 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-21957139

RESUMEN

During infection of humans and animals, pathogenic mycobacteria manipulate the host cell causing severe diseases such as tuberculosis and leprosy. To understand the basis of mycobacterial pathogenicity, it is crucial to identify the molecular virulence mechanisms. In this study, we address the contribution of ESX-1 and ESX-5--two homologous type VII secretion systems of mycobacteria that secrete distinct sets of immune modulators--during the macrophage infection cycle. Using wild-type, ESX-1- and ESX-5-deficient mycobacterial strains, we demonstrate that these secretion systems differentially affect subcellular localization and macrophage cell responses. We show that in contrast to ESX-1, the effector proteins secreted by ESX-5 are not required for the translocation of Mycobacterium tuberculosis or Mycobacterium marinum to the cytosol of host cells. However, the M. marinum ESX-5 mutant does not induce inflammasome activation and IL-1ß activation. The ESX-5 system also induces a caspase-independent cell death after translocation has taken place. Importantly, by means of inhibitory agents and small interfering RNA experiments, we reveal that cathepsin B is involved in both the induction of cell death and inflammasome activation upon infection with wild-type mycobacteria. These results reveal distinct roles for two different type VII secretion systems during infection and shed light on how virulent mycobacteria manipulate the host cell in various ways to replicate and spread.


Asunto(s)
Proteínas de Homeodominio/metabolismo , Inflamasomas/inmunología , Inflamasomas/metabolismo , Proteínas de Transporte de Membrana/metabolismo , Mycobacterium marinum/inmunología , Mycobacterium tuberculosis/inmunología , Proteínas Proto-Oncogénicas/metabolismo , Factores de Transcripción/metabolismo , Animales , Muerte Celular/inmunología , Línea Celular , Línea Celular Tumoral , Humanos , Inflamación/inmunología , Inflamación/microbiología , Inflamación/patología , Interleucina-1beta/metabolismo , Macrófagos Alveolares/inmunología , Macrófagos Alveolares/metabolismo , Macrófagos Alveolares/microbiología , Ratones , Mycobacterium marinum/patogenicidad , Mycobacterium tuberculosis/patogenicidad
4.
Enferm Infecc Microbiol Clin ; 28 Suppl 1: 46-50, 2010 Jan.
Artículo en Español | MEDLINE | ID: mdl-20172423

RESUMEN

The frequency of isolation as well as the number of species of non-tuberculous mycobacteria (NTM) has increased in the last years. Nearly every pathogenic species of NTM may cause skin and soft tissue infections, but rapidly growing mycobacteria (Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium abscessus), Mycobacterium marinum and Mycobacterium ulcerans are the most commonly involved. Many of these cutaneous mycobacteriosis, such as rapidly growing mycobacteria, M. marinum, Mycobacterium avium complex, Mycobacterium kansasii or Mycobacterium xenopi are world-wide distributed. In contrast, some others have a specific geographical distribution. This is the case of M. ulcerans, which causes a cutaneous diseases endemic of Central and West Africa (Buruli ulcer) and Australia (Bairnsdale ulcer), being the third mycobacterial infection after tuberculosis and leprosy. Cutaneous mycobacteriosis usually appear either after contact of traumatic or surgical wounds with water or other contaminated products, or, secondarily, as a consequence of a disseminated mycobacterial disease, especially among immunosuppressed patients. For an early diagnosis, it is necessary to maintain a high degree of suspicion in patients with chronic cutaneous diseases and a history of trauma, risk exposure and negative results of conventional microbiological studies. In general, individualized susceptibility testing is not recommended for most NTM infections, except for some species, and in case of therapeutic failure. Treatment includes a combination of different antimicrobial agents, but it must be taken into account that NTM are resistant to conventional antituberculous drugs. Severe cases or those with deep tissues involvement could also be tributary of surgical resection.


Asunto(s)
Infecciones por Mycobacterium no Tuberculosas , Enfermedades Cutáneas Bacterianas , Infecciones de los Tejidos Blandos , África Central/epidemiología , África Occidental/epidemiología , Antibacterianos/uso terapéutico , Australia/epidemiología , Úlcera de Buruli/epidemiología , Farmacorresistencia Bacteriana Múltiple , Humanos , Huésped Inmunocomprometido , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Infecciones por Mycobacterium no Tuberculosas/epidemiología , Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium marinum/aislamiento & purificación , Mycobacterium marinum/patogenicidad , Mycobacterium ulcerans/aislamiento & purificación , Mycobacterium ulcerans/patogenicidad , Micobacterias no Tuberculosas/aislamiento & purificación , Micobacterias no Tuberculosas/patogenicidad , Infecciones Oportunistas/epidemiología , Infecciones Oportunistas/microbiología , Enfermedades Cutáneas Bacterianas/diagnóstico , Enfermedades Cutáneas Bacterianas/tratamiento farmacológico , Enfermedades Cutáneas Bacterianas/epidemiología , Enfermedades Cutáneas Bacterianas/microbiología , Infecciones de los Tejidos Blandos/diagnóstico , Infecciones de los Tejidos Blandos/tratamiento farmacológico , Infecciones de los Tejidos Blandos/epidemiología , Infecciones de los Tejidos Blandos/microbiología , Microbiología del Suelo , Microbiología del Agua , Infección de Heridas/microbiología
5.
Annu Rev Microbiol ; 57: 641-76, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14527294

RESUMEN

Pathogenic mycobacteria, including the causative agents of tuberculosis and leprosy, are responsible for considerable morbidity and mortality worldwide. A hallmark of these pathogens is their tendency to establish chronic infections that produce similar pathologies in a variety of hosts. During infection, mycobacteria reside in macrophages and induce the formation of granulomas, organized immune complexes of differentiated macrophages, lymphocytes, and other cells. This review summarizes our understanding of Mycobacterium-host cell interactions, the bacterial-granuloma interface, and mechanisms of bacterial virulence and persistence. In addition, we highlight current controversies and unanswered questions in these areas.


Asunto(s)
Macrófagos/microbiología , Infecciones por Mycobacterium/microbiología , Mycobacterium/fisiología , Animales , Modelos Animales de Enfermedad , Genes Bacterianos , Granuloma/inmunología , Granuloma/microbiología , Humanos , Mycobacterium/patogenicidad , Complejo Mycobacterium avium/patogenicidad , Complejo Mycobacterium avium/fisiología , Mycobacterium leprae/patogenicidad , Mycobacterium leprae/fisiología , Mycobacterium marinum/patogenicidad , Mycobacterium marinum/fisiología , Mycobacterium tuberculosis/patogenicidad , Mycobacterium tuberculosis/fisiología , Virulencia
6.
s.l; s.n; s.ed; 1982. 10p tab.
No convencional en Inglés | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1241565

RESUMEN

We examined the possibility that the popliteal lymph node serves as the source of the lymphocytes that, together with macrophages, characterize the lesion produced by infection with Mycobacterium marinum in the hind footpad of the mouse...


Asunto(s)
Animales , Mycobacterium marinum/inmunología , Mycobacterium marinum/aislamiento & purificación , Mycobacterium marinum/patogenicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA